Terumo Corp. Stock Hits Day Low Amid Price Pressure, Reaches JPY 2,243.00

Terumo Corp., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline of 4.14% on June 2, 2026, reaching an intraday low of JPY 2,243.00. This performance stands in contrast to the Japan Nikkei 225, which saw a modest decrease of 0.3% on the same day. Over the past week, Terumo Corp. has faced a decline of 3.68%, while its performance over the last month shows a positive growth of 13.05%. However, the stock has struggled over the longer term, with a significant drop of 14.34% over the past year and a staggering 48.29% decline over the last three years. Despite these challenges, Terumo Corp. maintains a strong ability to service its debt, evidenced by a healthy EBIT to Interest ratio of 36.60. The company has also reported impressive net sales growth at an annual rate of 12.52%. With a market capitalization of JPY 3,554,824 million, Terumo Corp. continues to navigate a complex market landscape while facing pressures in both short-term and long-term performance metrics.